Across TCGA pan-cancer cohorts, OR6C70 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated OR6C70 data layer compared with 15 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher OR6C70 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated OR6C70 expression acts as an unfavorable survival marker.

COAD and LUAD are the cancer types where OR6C70 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	OS	Median	IV	0.089	0.649	.005	14	view →
LUAD	OS	Median	All	0.378	0.699	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: OR6C70 tumor-vs-normal RNA expression · all OR6C70 data types